Ketryx, the agentic continuous compliance platform for safety-critical product development, announced today that William A. Hawkins, former Chairman and CEO of Medtronic, has joined its Board of Directors. Hawkins also participated in the company’s Series B financing, underscoring his commitment to Ketryx's mission.
Ketryx helps companies in safety-critical industries, including medical devices, pharmaceuticals, and robotics, accelerate product development by automatically generating compliant documentation, maintaining continuous traceability, and enabling safe and verifiable AI at scale in the tools teams already use. The platform overlays existing tools to automate documentation, create traceability, and accelerate release cycles without disrupting existing workflows.
“We are honored to welcome Bill Hawkins to our Board,” said Stefan K. Schreiber, CEO of Ketryx. “His decades of leadership in the medical device industry and deep understanding of regulatory compliance will be invaluable as we scale our platform to help more life sciences teams deliver safer products faster.”
Hawkins served as Chairman and CEO of Medtronic from 2007 to 2011, leading the company through significant growth and innovation. He currently serves on the boards of several public and private companies. “Ketryx is addressing a critical need in safety-critical industries by automating compliance and traceability,” Hawkins said. “I look forward to contributing to the company’s growth and helping more teams bring products to market safely and efficiently.”
Ketryx is trusted by four of the world’s top five medical device manufacturers. Its AI Agents reduce manual work by up to 90 percent and help teams identify and close compliance gaps, improving both speed and quality across the product lifecycle. The company’s platform is designed to maintain continuous traceability and enable safe, verifiable AI at scale.
The addition of Hawkins to the board comes as Ketryx continues to expand its footprint in the life sciences industry. The company’s Series B financing round, which included participation from Hawkins, will support further product development and market expansion. For more information about Ketryx, visit www.ketryx.com.
